Literature DB >> 8259776

Antibodies to the constitutive 73-kd heat shock protein: a new marker of mixed connective tissue disease?

N Mairesse1, M F Kahn, T Appelboom.   

Abstract

PURPOSE, PATIENTS, AND METHODS: This report documents the finding of an elevated titer of IgG reacting with the constitutive bovine 73-kd heat shock protein (HSP) in the serum of patients with rheumatoid arthritis, scleroderma, and mixed connective tissue disease (MCTD). RESULTS AND
CONCLUSIONS: Further characterization of antibodies from patients with MCTD showed that the antibodies also recognize the human constitutive 73-kd HSP, but not the inducible 72-kd isoform. Very high levels of antibodies appeared to be specific for MCTD; the differences between levels in patients with MCTD and those in healthy subjects (blood donors) were highly significant (p < 10(-8)), with no values in this group of patients overlapping with those in the controls. This parameter might therefore represent a new diagnostic marker for this disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8259776     DOI: 10.1016/0002-9343(93)90355-s

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis.

Authors:  D Tontsch; S Pankuweit; B Maisch
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis.

Authors:  G Hayem; M De Bandt; E Palazzo; S Roux; B Combe; J F Eliaou; J Sany; M F Kahn; O Meyer
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

3.  Antibodies to small ribonucleoprotein and to 73-kD heat shock protein: two distinct markers of mixed connective tissue disease.

Authors:  T Appelboom; M F Kahn; N Mairesse
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.